ACH Overview

Accendra Health, Inc., formerly Owens & Minor, Inc., is a nationwide pure play home-based care platform. Its Patient Direct segment includes home healthcare divisions (Byram and Apria). The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States. It offers a range of products and services for in-home care and delivery, including diabetes treatment, home respiratory therapy (including home oxygen and non-invasive ventilation services), and obstructive sleep apnea treatment (including continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services). Additionally, it supplies a wide range of other home medical equipment, patient care product lines including ostomy, wound care (including negative pressure wound therapy), urology, incontinence and other products and services.

Wall Street analysts forecast ACH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACH is3.50 USD with a low forecast of 2.50 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Accendra Health Inc revenue for the last quarter amounts to 627.78M USD, decreased -6.84

Accendra Health Inc. EPS for the last quarter amounts to -0.08 USD, decreased -75.00

Accendra Health Inc (ACH) has 6500 emplpoyees as of May 26 2026.

Today ACH has the market capitalization of 216.73M USD.